Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole on HCMV DNA replication and permissive infection

Antiviral Research

Volumn 41, Issue 3, 1999, Pages 101-111

  Johnson, Robert A ^a,b   Huong, Shu Mei ^b   Huang, Eng Shang ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antiviral compound; FHPI; Human cytomegalovirus (HCMV); p38 MAPK

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL) 1H IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIVIRUS AGENT; GANCICLOVIR; MITOGEN ACTIVATED PROTEIN KINASE; SB 20219; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA REPLICATION; EMBRYO; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL SURVIVAL; CYTOMEGALOVIRUS; DNA REPLICATION; DNA, VIRAL; ENZYME INHIBITORS; FIBROBLASTS; GENES, IMMEDIATE-EARLY; HUMANS; IMIDAZOLES; IMMEDIATE-EARLY PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 0033009115     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(99)00002-9     Document Type: Article

References (36)

1. Baldanti F., Silini E., Sarasini A., Talarico C.L., Stanat S.C., Biron K.K., Furione M., Bono F., Palu G., Gerna G. A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J. Virol. 69:1995;796-800.
2. Baldanti F., Sarasini A., Silini E., Barbi M., Lazzarin A., Biron K.K., Gerna G. Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir and foscarnet-specific resistance, respectively. Scand. J. Infect. Dis. Suppl. 99:1995;103-104.
3. Baldanti F., Boeckh M., Chou S., Crumpacker C., Danner S., Drew W.L., Emanuel D., Erice A., Hardy W.D., Spector S. Drug resistance in cytomegalovirus: current knowledge and implications for patient management. J. Acq. Immune Defic. Syndr. Hum. Retroviral. (Suppl. 1). 12:1996;S1-S22.
4. Baldanti F., Underwood M.R., Talarico C.L., Simoncini L., Sarasini A., Biron K.K., Gerna G. The Cys607-Tyr change in UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patients. Antimicrob. Agents Chemother. 42:1998;444-446.
5. Bruening W., Giasson B., Mushynski W., Durham H.D. Activation of stress-activated MAP protein kinases up-regulates expression of transgenes driven by the cytomegalovirus immediate/early promoter. Nuc. Acids Res. 26:1998;486-489.
6. Cuenda A., Cohen P., Buee-Scherrer V., Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16:1997;295-305.
7. Dudding L., Haskill S., Clark B.D., Auron P.E., Sporn S., Huang E.S. Cytomegalovirus infection stimulates expression of monocyte-associated mediator genes. J. Immunol. 143:1989;3343-3352.
8. Enslen H., Raingeaud J., Davis R.J. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273:1998;1741-1748.
9. Han J., Lee J.-D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:1994;808-811.
10. He Y.S., Xu L., Huang E.S. Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product. J. Virol. 66:1992;1098-1108.
11. Huang E.-S., Kowalik T.F. The pathogenicity of human cytomegalovirus: an overview. Becker Y., Darai G., Huang E.S. Molecular Aspects of Human Cytomegalovirus Diseases. 1993;1-45 Springer-Verlag, Berlin.
12. Iordanov M., Bender K., Ade T., Schmid W., Sachsenmaier C., Engel K., Gaestel M., Rahmsdorf H.J., Herrlich P. CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J. 16:1997;1009-1022.
13. Kowalik, T.F., Wing, B., Haskill, J.S., Azizkhan, J.C., Baldwin, A.S. Jr. and Huang, E.-S. 1993. Multiple mechanisms are implicated in the regulation of NF-κB activity during human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA. 90, 1107-1111.
14. Kowalik T.F., Yurochko A.D., Rinehart C.A., Lee C.Y., Huang E.S. Productive infection of human endometrial stromal cells by human cytomegalovirus. Virology. 202:1994;247-257.
15. Larsen C.M., Wadt K.A.W., Juhl L.F., Anderson H.U., Karlsen A.E., Su M.S.-S., Seedorf K., Shapiro L., Dinarello C.A., Mandrup-Poulsen T. Interleukin-1(-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Biol. Chem. 273:1998;15294-15300.
16. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W., Strickler J.E., McLaughlin M.M., Siemens I.R., Fisher S.M., Livi G.P., White J.R., Adams J.L., Young P.R. A protein kinase involved in the regulation of inflammatory cytokine bioisynthesis. Nature. 372:1994;739-746.
17. Mar E.-C., Cheng Y.-C., Huang E.-S. Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on human cytomegalovirus replication in vitro. Antimicrob. Agents Chemother. 24:1983;518-521.
18. Mocarski E.S. Cytomegalovirus biology and replication. Roizman B., Whitley R., Lopez C. The Human Herpesviruses. 1993;173-226 Raven Press, New York.
19. Nemoto S., Xiang J., Huang S., Lin A. Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase. J. Biol. Chem. 273:1998;16415-16420.
20. Pari G.S., Anders D.G. Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J. Virol. 67:1993;6979-6988.
21. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., Davis R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:1995;7420-7426.
22. Read M.A., Whitley M.Z., Gupta S., Pierce J.W., Best J., Davis R.J., Collins T. Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor κB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 272:1997;2753-2761.
23. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A.R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 78:1994;1027-1037.
24. Sarisky R.T., Hayward G.S. Evidence that the UL84 gene product of human cytomegalovirus is essential for promoting oriLyt-depdendent DNA replication and formation of replication compartments in cotransfection assays. J. Virol. 70:1996;7398-7413.
25. Serody J.S., van der Horst C.M. The control of cytomegalovirus infection: chemotherapy. Becker Y., Darai G., Huang E.S. Molecular Aspects of Human Cytomegalovirus Diseases. 1993;256-282 Springer-Verlag, Berlin.
26. Shapiro L., Heidenreich K.A., Meintzer M.D., Dinarello C.A. Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc. Natl. Acad. Sci. USA. 95:1998;7422-7426.
27. Stamminger T., Fickenscher H., Fleckenstein B. Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. J. Gen. Virol. 71:1990;105-113.
28. Stanat S.C., Reardon J.E., Erice A., Jordan M.C., Drew W.L., Biron K.K. Ganciclovir-resistant cytomegalovirus clinical isolate: mode of resistance to ganciclovir and phosphonylmethoxy-alkyl derivatives. Antimicrob. Agent Chemother. 35:1991;2191-2197.
29. Stinski M.F., Malone C.L., Hermiston T.W., Liu B. Regulation of cytomegalovirus transcription. Wagner E.K. Herpesvirus Transcription and its Control. 1991;245-260 CRC Press, Boca Raton.
30. Stinski M.F., Malone C.L., Hermiston T.W., Liu B. Regulation of human cytomegalovirus transcription. Wagner E.K. Herpesvirus Transcription and Its Control. 1991;245-260 CRC Press, Boca Raton.
31. Tan Y., Rouse J., Zhang A., Cariati S., Cohen P., Comb M. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO. 15:1996;4629-4642.
32. Wang X.S., Diener K., Manthey C.L., Wang S.-w., Rosenzweig B., Bray J., Delaney J., Coles C.N., Chan-Hui P.-Y., Mantlo N., Lichenstein H.S., Zukowski M., Yao Z. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J. Biol. Chem. 272:1997;23668-23674.
33. Whitmarsh A.J., Yana S.-H., Su M.S.-S., Sharrocks A.D., Davis R.J. Role of p38 and JNK mitogen activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17:1997;2360-2371.
34. Wing B.A., Lee G.C.Y., Huang E.-S. The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics. J. Virol. 70:1996;3339-3345.
35. Young P.R., McLaughlin M.M., Kumar S., Kassis S., Doyle M.L., McNulty D., Gallagher T.F., Fisher S., McDonnell P.C., Carr S.A., Huddleston M.J., Seibel G., Porter T.G., Livi G.P., Adams J.L., Lee J.C. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J. Biol. Chem. 272:1997;12116-12121.
36. Yurochko, A.D. 1998. Unpublished data.